Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
456
datasets available to search
ShareScore release 0.9.0
Dataset results
456 results for “mesothelioma”
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
ClinicalTrials.gov study NCT04300244. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
ClinicalTrials.gov study NCT04287829. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
ClinicalTrials.gov study NCT00019825. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
ClinicalTrials.gov study NCT00004920. IPD Sharing: Not stated. Countries: 11. Publications: 4.
CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma
ClinicalTrials.gov study NCT03063450. IPD Sharing: YES. Countries: 1. Publications: 2.
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
ClinicalTrials.gov study NCT00003508. IPD Sharing: NO. Countries: 1. Publications: 0.
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
ClinicalTrials.gov study NCT04334759. IPD Sharing: NO. Countries: 3. Publications: 3.
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
ClinicalTrials.gov study NCT04177953. IPD Sharing: NO. Countries: 1. Publications: 1.
Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma
ClinicalTrials.gov study NCT02141347. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
ClinicalTrials.gov study NCT01766739. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Niraparib Efficacy in Patient With Unresectable Mesothelioma
ClinicalTrials.gov study NCT05455424. IPD Sharing: YES. Countries: 1. Publications: 1.
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
ClinicalTrials.gov study NCT05001880. IPD Sharing: YES. Countries: 1. Publications: 1.
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
ClinicalTrials.gov study NCT03654833. IPD Sharing: NO. Countries: 1. Publications: 2.
Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT05508555. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT00407459. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov study NCT00821860. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
ClinicalTrials.gov study NCT01950572. IPD Sharing: YES. Countries: 1. Publications: 1.
Intrapleural Gene Transfer for Pleural Mesothelioma
ClinicalTrials.gov study NCT01212367. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT01486368. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
ClinicalTrials.gov study NCT02588131. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.